Key result
A negative carotid plaque area test (CPA=0) yielded a superior negative predictive value (74% vs 65%) and likelihood ratio (0.48 vs 0.72) compared to a coronary calcium score of 0 for detecting CAD.
Why the study?
Does carotid plaque area measurement improve the detection of clinically significant coronary artery disease compared to coronary calcium score, intima-media thickness, and C-reactive protein in patients undergoing coronary CTA?
Population
42 patients who had a 16-slice coronary computed tomography angiogram (CTA) performed
Comparison
Carotid plaque area (CPA) measurement vs Coronary calcium score, carotid intima-media…
Design
Cross-sectional
Authors
Loading...
Negative CPA may aid CAD rule-out versus CCS=0 on CTA; leaves open prospective validation in larger cohorts.
Cross-Sectional (n=42)
Does carotid plaque area measurement improve the detection of clinically significant coronary artery disease compared to coronary calcium score, intima-media thickness, and C-reactive protein in patients undergoing coronary CTA?
Effect estimate: LR 0.48
Absolute Event Rate: 74% vs 65%
Carotid plaque area measurement may be superior to coronary calcium score, IMT, and CRP for ruling out clinically significant coronary artery disease.
Brook et al. (2005) conducted a cross-sectional in Coronary artery disease (n=42). Carotid plaque area (CPA) vs. Coronary calcium score (CCS), intima-media thickness (IMT), and C-reactive protein (CRP) was evaluated on Presence of clinically significant coronary artery disease (CAD) defined as any stenosis ≥50% (LR 0.48). A negative carotid plaque area test (CPA=0) yielded a superior negative predictive value (74% vs 65%) and likelihood ratio (0.48 vs 0.72) compared to a coronary calcium score of 0 for detecting CAD.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: